Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/24204
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-01-21T07:18:47Z-
dc.date.available2022-01-21T07:18:47Z-
dc.date.issued2001-
dc.identifier.citationSavcı, V. vd. (2001). "Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine". Pharmacology, 62(1), 36-44.en_US
dc.identifier.issn0031-7012-
dc.identifier.urihttps://doi.org/10.1159/000056070-
dc.identifier.urihttps://www.karger.com/Article/Abstract/56070-
dc.identifier.urihttp://hdl.handle.net/11452/24204-
dc.description.abstractThe cardiovascular effects of tetrahydroaminoacridine (tacrine; THA) were investigated in haemorrhaged rats. Intracerebroventricular (i.c.v.) injection of THA (10, 25 and 50 mug) restored blood pressure in a dose- and time-dependent manner. Atropine (10 mug, i.c.v.), a muscarinic receptor antagonist, attenuated the presser response to THA (25 mug, i.c.v.), while mecamylamine (50 mug, i.c.v.), a nicotinic receptor antagonist, caused only a slight blockade in the presser effect of THA. Simultaneous pretreatment with atropine and mecamylamine almost abolished the blood pressure effect of i.c.v. THA (25 mug). Haemorrhage increased plasma levels of adrenaline, noradrenaline, vasopressin and plasma renin activity. THA (25 mug, i.c.v.) administration caused additional increases in vasopressin and adrenaline levels but not of renin activity and noradrenaline levels. The reversal of hypotension by THA was greatly attenuated by administration of either prazosin, an al-adrenoceptor antagonist (0.5 mg/kg, i.v.) or by the vasopressin V-1 receptor antagonist [beta -mercapto-beta,beta -cyclopenta-methylenepropionyl(1), O-Me-Tyr(2)-Arg(8)]-vasopressin (10 mug/kg, i.v.). Pretreatment of rats with both prazosin and the vasopressin antagonist simultaneously completely inhibited the presser response. Intravenous administration of THA (1, 1.5 and 3 mg/kg) also reversed hypotension in rats. Atropine (10 mug, i.c.v.) greatly attenuated the presser response to THA (1.5 mg/kg, i.v.), while mecamylamine (50 mug, i.c.v.) failed to change the presser effect of THA. In anaesthetised haemorrhaged rats, THA (1.5 mg/kg, i.v.) increased blood pressure and survival time of the animals. These results show that centrally and peripherally injected THA reverses haemorrhagic hypotension and increases survival time in rats. Activation of central muscarinic and nicotinic receptors is involved in the presser response to i.c.v. THA. The presser effect of i.v. THA is solely mediated by central muscarinic receptors. Moreover, the increase in plasma adrenaline and vasopressin levels appears to be involved in the presser effect of THA.en_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHaemorrhageen_US
dc.subjectAdrenalineen_US
dc.subjectBlood pressureen_US
dc.subjectCholinergic receptor mechanismsen_US
dc.subjectCholinesterase inhibitoren_US
dc.subjectHypotensionen_US
dc.subjectTetrahydroaminoacridineen_US
dc.subjectVasopressinen_US
dc.subjectAcetylcholine-releaseen_US
dc.subjectNervous-systemen_US
dc.subjectBlood-pressureen_US
dc.subjectTacrineen_US
dc.subjectCholineen_US
dc.subjectBrainen_US
dc.subjectPhysostigmineen_US
dc.subjectInvivoen_US
dc.subjectM(2)en_US
dc.subject.meshAdrenergic alpha-antagonistsen_US
dc.subject.meshAnesthetics, intravenousen_US
dc.subject.meshAnimalsen_US
dc.subject.meshSurvival analysisen_US
dc.subject.meshCardiovascular agentsen_US
dc.subject.meshCholinesterase inhibitorsen_US
dc.subject.meshEpinephrineen_US
dc.subject.meshAtropineen_US
dc.subject.meshBlood pressureen_US
dc.subject.meshDose-response relationship, drugen_US
dc.subject.meshFemaleen_US
dc.subject.meshHypotensionen_US
dc.subject.meshInjections, intravenousen_US
dc.subject.meshInjections, intraventricularen_US
dc.subject.meshMaleen_US
dc.subject.meshMecamylamineen_US
dc.subject.meshNorepinephrineen_US
dc.subject.meshPrazosinen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, wistaren_US
dc.subject.meshReceptors, vasopressinen_US
dc.subject.meshReninen_US
dc.subject.meshShock, hemorrhagicen_US
dc.subject.meshTacrineen_US
dc.subject.meshTime factorsen_US
dc.subject.meshUrethaneen_US
dc.subject.meshVasopressinsen_US
dc.titleReversal of haemorrhagic shock in rats by tetrahydroaminoacridineen_US
dc.typeArticleen_US
dc.identifier.wos000166591900007tr_TR
dc.identifier.scopus2-s2.0-0035165180tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Farmakoloji ve Klinik Darmakoloji Anabilim Dalı.tr_TR
dc.identifier.startpage36tr_TR
dc.identifier.endpage44tr_TR
dc.identifier.volume62tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalPharmacologyen_US
dc.contributor.buuauthorSavcı, Vahide-
dc.contributor.buuauthorÇavun, Sinan-
dc.contributor.buuauthorGürun, Mine Sibel-
dc.contributor.buuauthorUlus, İsmail Hakkı-
dc.contributor.researcheridAAG-8716-2019tr_TR
dc.contributor.researcheridAAC-9702-2019tr_TR
dc.contributor.researcheridD-5340-2015tr_TR
dc.identifier.pubmed11150921tr_TR
dc.subject.wosPharmacology & pharmacyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2en_US
dc.contributor.scopusid6603687024tr_TR
dc.contributor.scopusid6507468595tr_TR
dc.contributor.scopusid55664349700tr_TR
dc.contributor.scopusid7004271086tr_TR
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholineen_US
dc.subject.emtreePrazosinen_US
dc.subject.emtreeAdrenalinen_US
dc.subject.emtreeAtropineen_US
dc.subject.emtreeMecamylamineen_US
dc.subject.emtreeMuscarinic receptoren_US
dc.subject.emtreeNicotinic receptoren_US
dc.subject.emtreeNoradrenalinen_US
dc.subject.emtreeTacrineen_US
dc.subject.emtreeNoradrenalin blood levelen_US
dc.subject.emtreeVasopressinen_US
dc.subject.emtreeVasopressin receptor antagonisten_US
dc.subject.emtreeAdrenalin blood levelen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreePressor responseen_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeFemale hypotensionen_US
dc.subject.emtreeBlood pressure regulationen_US
dc.subject.emtreeCardiovascular effecten_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDose time effect relationen_US
dc.subject.emtreeHemorrhagic shocken_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePlasma renin activityen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeSurvivalen_US
dc.subject.emtreeVasopressin blood levelen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.